Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)

NCT04519957 is registered in ClinicalTrials.gov with COMPASS Pathways as lead sponsor.

NCT NCT04519957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)
Lead sponsor
COMPASS Pathways
Phase
Observational
Overall status
Completed
Start date
July 20, 2020
Completion date
August 11, 2022
Enrollment
66 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression